Cargando…
N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
BACKGROUND: Niemann-Pick disease type C (NPC) is a rare autosomal recessive neurodegenerative lysosomal disease characterized by multiple symptoms such as progressive cerebellar ataxia and cognitive decline. The modified amino acid N-acetyl-leucine has been associated with positive symptomatic and n...
Autores principales: | Fields, T, M. Bremova, T, Billington, I, Churchill, GC, Evans, W, Fields, C, Galione, A, Kay, R, Mathieson, T, Martakis, K, Patterson, M, Platt, F, Factor, M, Strupp, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226221/ https://www.ncbi.nlm.nih.gov/pubmed/37248494 http://dx.doi.org/10.1186/s13063-023-07399-6 |
Ejemplares similares
-
A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
por: Fields, T., et al.
Publicado: (2021) -
Acetylation turns leucine into a drug by membrane transporter switching
por: Churchill, Grant C., et al.
Publicado: (2021) -
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
por: Bremova-Ertl, Tatiana, et al.
Publicado: (2021) -
Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance
por: Churchill, Grant C., et al.
Publicado: (2020) -
Retinal axonal degeneration in Niemann–Pick type C disease
por: Havla, Joachim, et al.
Publicado: (2020)